Identity
- Trade Name
- HardyDisk™ FDA UDI
- Generic Name
- Antibacterial susceptibility testing disc IVD FDA UDI
- Device Name
- Kanamycin, 1000mcg, differentiates anaerobic bacteria on the basis of susceptibility to kanamycin, 1 x 50 disks, for ID of anaerobes Differentiates anaerobic bacteria on the basis of susceptibility to kanamycin. FDA UDI
- Model / Reference
- Z7191 FDA UDI
- Description
- Kanamycin, 1000mcg, differentiates anaerobic bacteria on the basis of susceptibility to kanamycin, 1 x 50 disks, for ID of anaerobes Differentiates anaerobic bacteria on the basis of susceptibility to kanamycin. FDA UDI
Identifiers
- Catalog Number
- Z7191 FDA UDI
- Primary DI / UDI-DI
- 00816576028450 FDA UDI
- FDA Product Code
- JTO FDA UDI
- GMDN Term
- Antibacterial susceptibility testing disc IVD FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 866.2660 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Antibacterial susceptibility testing disc IVD
HardyDisk™ by Hardy Diagnostics — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Antibacterial susceptibility testing disc IVD.
- BD BBL™ Sensi-Disc™ Bacitracin 10 units — BECTON DICKINSON AND COMPANY · Class II
- BD BBL™ Sensi-Disc™ Levofloxacin 5 µg — BECTON DICKINSON AND COMPANY · Class II
- BD BBL™ Sensi-Disc™ Oxytetracycline 30 µg — BECTON DICKINSON AND COMPANY · Class II
- BD BBL™ Sensi-Disc™ Azithromycin 15 µg — BECTON DICKINSON AND COMPANY · Class II
- BD BBL™ Sensi-Disc™ Oxacillin 1 µg — BECTON DICKINSON AND COMPANY · Class II
- BD BBL™ Sensi-Disc™ Nitrofurantoin 300 µg — BECTON DICKINSON AND COMPANY · Class II
- BD BBL™ Sensi-Disc™ Bacitracin 2 units — BECTON DICKINSON AND COMPANY · Class II
- BD BBL™ Sensi-Disc™ Streptomycin 300 µg — BECTON DICKINSON AND COMPANY · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Hardy Diagnostics
Sources (1)
- FDA UDI 371167be-65ae-40c7-b630-76d468234c26 36 fields · synced Jun 1, 2026